# Genistein, Equol, Cognitive Function and Mood: Acute. (GECFAMa)

> **NCT07742514** · NA · COMPLETED · sponsor: **University of Reading** · enrollment: 53 (actual)

## Conditions studied

- Cognition
- Mood

## Interventions

- **DIETARY_SUPPLEMENT:** Genistein
- **DIETARY_SUPPLEMENT:** Equol
- **DIETARY_SUPPLEMENT:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT07742514
- **Lead sponsor:** University of Reading
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-14
- **Primary completion:** 2025-10-14
- **Final completion:** 2025-10-14
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07742514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07742514, "Genistein, Equol, Cognitive Function and Mood: Acute. (GECFAMa)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07742514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*